Literature DB >> 25492047

Bone marrow mesenchymal stem cells suppressing activation of allogeneic cytokine-induced killer/natural killer cells either by direct or indirect interaction.

Yang Li1, Yu H Qu, Yan F Wu, Ling Liu, Xiang H Lin, Ke Huang, Jing Wei.   

Abstract

Bone marrow mesenchymal stem cells (MSC) were recently found to be associated with some special immunological characteristics, the immunoregulatory effect of MSC was dose-dependent. Low amount of MSC was associated with mild immunosuppression or even immune activation, while the high amount of that was associated with significant immunosuppressive effect. In this study, by using a transwell system, we explored the effect of MSC on the cell cycle, apoptosis rate and the expression of CD69, an activation marker, on the allogeneic cord blood derived cytokine-induced killer(CIK)/natural killer(NK) cells. The results showed that either by transwell or mixed cell-cell co-culture, the MSC can effect CIK/NK cells on the cell cycle, such as arrested in the G0/G1 phase, diminished the ratio of cells in S, G2/M phase, and increased the apoptosis of them. MSC can also depress the expression of CD69 on these killer cells, as well as increased the ratio of CD4(+) CD25(+) CD127(low) T regulatory (Treg) cells in the CIK/NK cell culture system. We draw conclusions that either by transwell or mixed co-culture, the MSC can suppress activation of allogeneic CB-CIK/NK cells in a dose-dependent manner.
© 2014 International Federation for Cell Biology.

Entities:  

Keywords:  bone marrow; cell surface molecules; cytokine-induced killer cell; mesenchymal stem cell

Mesh:

Substances:

Year:  2015        PMID: 25492047     DOI: 10.1002/cbin.10404

Source DB:  PubMed          Journal:  Cell Biol Int        ISSN: 1065-6995            Impact factor:   3.612


  8 in total

1.  Umbilical cord blood transplantation supplemented with the infusion of mesenchymal stem cell for an adolescent patient with severe aplastic anemia: a case report and review of literature.

Authors:  Chengxin Luan; Runzhe Chen; Baoan Chen; Jiahua Ding; Ming Ni
Journal:  Patient Prefer Adherence       Date:  2015-06-11       Impact factor: 2.711

Review 2.  Mesenchymal Stem and Progenitor Cells in Normal and Dysplastic Hematopoiesis-Masters of Survival and Clonality?

Authors:  Lisa Pleyer; Peter Valent; Richard Greil
Journal:  Int J Mol Sci       Date:  2016-06-27       Impact factor: 5.923

3.  Improved osteogenesis and upregulated immunogenicity in human placenta-derived mesenchymal stem cells primed with osteogenic induction medium.

Authors:  Xuejie Fu; Huilin Yang; Hui Zhang; Guichao Wang; Ke Liu; Qiaoli Gu; Yunxia Tao; Guangcun Chen; Xiaohua Jiang; Gang Li; Yanzheng Gu; Qin Shi
Journal:  Stem Cell Res Ther       Date:  2016-09-20       Impact factor: 6.832

4.  Human dental pulp stem cells regulate allogeneic NK cells' function via induction of anti-inflammatory purinergic signalling in activated NK cells.

Authors:  Fei Yan; Ousheng Liu; Haixia Zhang; Yueying Zhou; Dian Zhou; Zekun Zhou; Yuhong He; Zhangui Tang; Songlin Wang
Journal:  Cell Prolif       Date:  2019-04-05       Impact factor: 6.831

5.  Comparative analysis of mesenchymal stem cells derived from amniotic membrane, umbilical cord, and chorionic plate under serum-free condition.

Authors:  Jiao Ma; Jun Wu; Lei Han; Xiangxiang Jiang; Long Yan; Jie Hao; Hongmei Wang
Journal:  Stem Cell Res Ther       Date:  2019-01-11       Impact factor: 6.832

6.  Research Status of Mesenchymal Stem Cells in Liver Transplantation.

Authors:  Yu You; Di-Guang Wen; Jian-Ping Gong; Zuo-Jin Liu
Journal:  Cell Transplant       Date:  2019-09-12       Impact factor: 4.064

Review 7.  Mesenchymal stem cells and natural killer cells interaction mechanisms and potential clinical applications.

Authors:  Batol Abbasi; Karim Shamsasenjan; Majid Ahmadi; Seyedeh Ameneh Beheshti; Mahshid Saleh
Journal:  Stem Cell Res Ther       Date:  2022-03-07       Impact factor: 6.832

Review 8.  Mesenchymal Stem Cells: Allogeneic MSC May Be Immunosuppressive but Autologous MSC Are Dysfunctional in Lupus Patients.

Authors:  Rui-Juan Cheng; An-Ji Xiong; Yan-Hong Li; Shu-Yue Pan; Qiu-Ping Zhang; Yi Zhao; Yi Liu; Tony N Marion
Journal:  Front Cell Dev Biol       Date:  2019-11-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.